Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Expression of C4.4A is a Potential Independent Prognostic Factor for Patients with Gastric Cancer

  • Cheng, Da-Qing (Department of General Surgery, Huashan Hospital, Fudan University) ;
  • Gu, Xiao-Dong (Department of General Surgery, Huashan Hospital, Fudan University) ;
  • Li, Zhen-Yang (Department of General Surgery, Huashan Hospital, Fudan University) ;
  • Xiang, Jian-Bin (Department of General Surgery, Huashan Hospital, Fudan University) ;
  • Chen, Zong-You (Department of General Surgery, Huashan Hospital, Fudan University)
  • Published : 2014.05.15
Download PDF
⟨ Previous Next ⟩

Abstract

C4.4A, a metastasis-associated gene, encodes a glycolipid-anchored membrane protein which is overexpressed in several human malignancies. However, there are few data available on C4.4A expression and its relationship with progression in gastric cancer. Our study was designed to explore the expression of C4.4A in gastric cancer and to correlate it with clinical outcome. C4.4A expression was studied by quantitative real-time RT-PCR and immunohistochemistry for assessment of correlations with clinicopathological factors. C4.4A mRNA expression was significantly up-regulated in gastric cancer as compared with noncancerous tissue (p<0.05)., being observed in 107 (88.4%) of the 121 gastric cancer cases by immunohistochemistry. We found that the expression of C4.4A mRNA was correlated with size of the tumor, depth of invasion, lymph node metastasis, distant metastasis and TNM stage. Moreover, patients with overexpression of C4.4A has a significantly worse survival (p<0.05). Further multivariable analysis indicated that the expression of C4.4A was an independent prognostic indicator for gastric cancer (p<0.05). In conclusion, overexpression of C4.4A correlates with metastatic potential of gastric cancer and C4.4A could be a novel independent prognostic marker for predicting outcome.

Keywords

References

  1. Esselens CW, Malapeira J, Colome N, et al (2008). Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17. Biol Chem, 389, 1075-84.
  2. Fletcher GC, Patel S, Tyson K, et al (2003). hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br J Cancer, 88, 579-85. https://doi.org/10.1038/sj.bjc.6600740
  3. Frank DE, Carter WG (2004). Laminin 5 deposition regulates keratinocyte polarization and persistent migration. J Cell Sci, 117, 1351-63. https://doi.org/10.1242/jcs.01003
  4. Fries F, Nazarenko I, Hess J, et al (2007). CEBPbeta, JunD and c-Jun contribute to the transcriptional activation of the metastasis-associated C4.4A gene. Int J Cancer, 120, 2135-47. https://doi.org/10.1002/ijc.22447
  5. Gao XH, Yang XQ, Wang BC, Liu SP, Wang FB (2013). Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer. Asian Pac J Cancer Prev, 14, 5055-60. https://doi.org/10.7314/APJCP.2013.14.9.5055
  6. Hansen LV, Gardsvoll H, Nielsen BS, et al (2004). Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor. Biochem J, 380, 845-57. https://doi.org/10.1042/BJ20031478
  7. Hansen LV, Laerum OD, Illemann M, Nielsen BS, Ploug M (2008). Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma. Int J Cancer, 122, 734-41. https://doi.org/10.1002/ijc.23082
  8. Hansen LV, Skov BG, Ploug M, Pappot H (2007). Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer. Lung Cancer, 58, 260-6. https://doi.org/10.1016/j.lungcan.2007.06.025
  9. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ (2009). Gastric cancer. Lancet, 374, 477-90. https://doi.org/10.1016/S0140-6736(09)60617-6
  10. Jacobsen B, Ploug M (2008). The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibition. Curr Med Chem, 15, 2559-73. https://doi.org/10.2174/092986708785909012
  11. Jemal A, Center MM, DeSantis C, Ward EM (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907. https://doi.org/10.1158/1055-9965.EPI-10-0437
  12. Konishi K, Yamamoto H, Mimori K, et al (2010). Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancer. Cancer Sci, 101, 2269-77. https://doi.org/10.1111/j.1349-7006.2010.01674.x
  13. Li FX, Zhang RP, Liang H, et al (2013). Validity and necessity of sub-classification of N3 in the 7th UICC TNM stage of gastric cancer. Asian Pac J Cancer Prev, 14, 2091-5. https://doi.org/10.7314/APJCP.2013.14.3.2091
  14. Ma YY, Tao HQ (2012). Role of urokinase plasminogen activator receptor in gastric cancer: a potential therapeutic target. Cancer Biother Radiopharm, 27, 285-90. https://doi.org/10.1089/cbr.2012.1232
  15. Matzku S, Wenzel A, Liu S, Zoller M (1989). Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. Cancer Res, 49, 1294-9.
  16. Mondino A, Resnati M, Blasi F (1999). Structure and function of the urokinase receptor. Thromb Haemost, 82, 19-22.
  17. Omejc M, Juvan R, Jelenc F, Repse S (2001). Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification. Int Surg, 86, 14-9.
  18. Paret C, Bourouba M, Beer A, et al (2005). Ly6 family member C4.4A binds laminins 1 and 5, associates with galectin-3 and supports cell migration. Int J Cancer, 115, 724-33. https://doi.org/10.1002/ijc.20977
  19. Paret C, Hildebrand D, Weitz J, et al (2007). C4.4A as a candidate marker in the diagnosis of colorectal cancer. Br J Cancer, 97, 1146-56. https://doi.org/10.1038/sj.bjc.6604012
  20. Rosel M, Claas C, Seiter S, Herlevsen M, Zoller M (1998). Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumor. Oncogene, 17, 1989-2002. https://doi.org/10.1038/sj.onc.1202079
  21. Sadowski T, Dietrich S, Koschinsky F, et al (2005). Matrix metalloproteinase 19 processes the laminin 5 gamma 2 chain and induces epithelial cell migration. Cell Mol Life Sci, 62, 870-80. https://doi.org/10.1007/s00018-005-4478-8
  22. Seiter S, Stassar M, Rappl G, et al (2001). Upregulation of C4.4A expression during progression of melanoma. J Invest Dermatol, 116, 344-7. https://doi.org/10.1046/j.1523-1747.2001.01230.x
  23. Smith BA, Kennedy WJ, Harnden P, et al (2001). Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium. Cancer Res, 61, 1678-85.
  24. Udayakumar TS, Chen ML, Bair EL, et al (2003). Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration. Cancer Res, 63, 2292-9.
  25. Wang J, Yu JC, Kang WM, Ma ZQ (2012). Treatment strategy for early gastric cancer. Surg Oncol, 21, 119-23. https://doi.org/10.1016/j.suronc.2010.12.004
  26. Wurfel J, Seiter S, Stassar M, et al (2001). Cloning of the human homologue of the metastasis-associated rat C4.4A. Gene, 262, 35-41. https://doi.org/10.1016/S0378-1119(00)00515-1
  27. Yamamoto H, Oshiro R, Ohtsuka M, et al (2013). Distinct expression of C4.4A in colorectal cancer detected by different antibodies. Int J Oncol, 42, 197-201. https://doi.org/10.3892/ijo.2012.1714

Cited by

  1. Expression of the Ly6/uPAR-Domain Proteins C4.4A and Haldisin in Non-Invasive and Invasive Skin Lesions vol.63, pp.2, 2015, https://doi.org/10.1369/0022155414563107